Takenouchi, Norihiro
Kansai Medical University
6 papers on CoChatORCID 0000-0002-7924-8468
Most cited papers
- Verified
Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp
Nagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, N., Moritoyo, T., Hashiguchi, S., Ichinose, M., Bangham, C. R., Izumo, S., et al. (1998) · Journal of Neurovirology
T-cell and Retrovirus StudiesHIV Research and Treatment
Cited by 694
- Verified
Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo
Furuta, R., Yasunaga, J.-I., Miura, M., Sugata, K., Saito, A., Akari, H., Ueno, T., Takenouchi, N., Fujisawa, J.-I., Koh, K.-R., et al. (2017) · PLOS Pathogens
T-cell and Retrovirus StudiesHIV Research and Treatment
Cited by 83
- Verified
An animal model of adult T-cell leukemia: humanized mice with HTLV-1–specific immunity
Tezuka, K., Xun, R., Tei, M., Ueno, T., Tanaka, M., Takenouchi, N., & Fujisawa, J.-I. (2014) · Blood
T-cell and Retrovirus StudiesViral-associated cancers and disorders
Cited by 68
- Verified
Decreased Human T Lymphotropic Virus Type I (HTLV‐I) Provirus Load and Alteration in T Cell Phenotype after Interferon‐α Therapy for HTLV‐I–Associated Myelopathy/Tropical Spastic Paraparesis
Saito, M., Nakagawa, M., Kaseda, S., Matsuzaki, T., Jonosono, M., Eiraku, N., Kubota, R., Takenouchi, N., Nagai, M., Furukawa, Y., et al. (2004) · The Journal of Infectious Diseases
T-cell and Retrovirus StudiesHIV Research and Treatment
Cited by 52
- Verified
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study
Coler-Reilly, A. L. G., Sato, T., Matsuzaki, T., Nakagawa, M., Niino, M., Nagai, M., Nakamura, T., Takenouchi, N., Araya, N., Yagishita, N., et al. (2017) · Neurotherapeutics
T-cell and Retrovirus StudiesInfectious Diseases and Tuberculosis
Cited by 39
- Verified
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy
Sato, T., Nagai, M., Watanabe, O., Misu, T., Takenouchi, N., Ohkubo, R., Ishihara, S., Tsuboi, Y., Katsuno, M., Nakagawa, M., et al. (2024) · Journal of Neurology
T-cell and Retrovirus StudiesInfectious Diseases and Tuberculosis
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free